<noscript lang="emlcpR"></noscript><ins id="O8hIe"></ins> VSports - Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The VSports app下载. gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

Editorial
. 2021 May 13;137(19):2565-2566.
doi: 10.1182/blood.2020010132.

V体育官网入口 - A step closer to GVL without GVHD

Affiliations
Editorial

"V体育平台登录" A step closer to GVL without GVHD

Christoph Schmid. Blood. .
No abstract available

PubMed Disclaimer

"V体育ios版" Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Figures

None
Options for integration of mLSTs into multimodal concepts for prevention and treatment of leukemia relapse after hematopoietic stem cell transplantation (HSCT): production before HSCT or during engraftment, allowing for early adjuvant mLST infusion (A), drug-based bridging after engraftment until delayed adjuvant mLST infusion (B), and combining drug-based disease control of overt hematological relapse, followed by maintenance with mLST infusion and additional treatment based on the mechanism of relapse (C). Professional illustration by Somersault18:24.

Comment on (V体育ios版)

References

    1. Lulla PD, Naik S, Vasileiou S, et al. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021;137(19):2585-2597. - PMC - PubMed
    1. Zeiser R, Beelen DW, Bethge W, et al. Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019;25(4):e128-e140. - PubMed
    1. Roex MCJ, Hageman L, Veld SAJ, et al. A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity. Blood. 2020;136(4):455-467. - "VSports最新版本" PubMed
    1. van Bergen CA, van Luxemburg-Heijs SA, de Wreede LC, et al. Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response. J Clin Invest. 2017;127(2):517-529. - PMC - PubMed
    1. Falkenburg F, Ruggiero E, Bonini C, et al. Prevention and treatment of relapse after stem cell transplantation by cellular therapies. Bone Marrow Transplant. 2019;54(1):26-34. - PubMed